One step closer to controlling LDL-c levels in HoFH with PCSK9i - PACE-CME

One step closer to controlling LDLc levels in HoFH with PCSKi

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Reduced bleeding with P2Y12i monotherapy after 3 months DAPT after complex PCI
Reduced bleeding with P2Y12i monotherapy after 3 months DAPT after complex PCI
ACC 2020
Reduced bleeding with P2Y12i monotherapy after 3 months DAPT after complex PCI
- Prof. George Dangas, MD, PhD
Remarkable reduction of LDL-c with antibody against angiopoietin-like protein 3 in HoFH
Remarkable reduction of LDL-c with antibody against angiopoietin-like protein 3 in HoFH
ACC 2020
Remarkable reduction of LDL-c with antibody against angiopoietin-like protein 3 in HoFH
- Prof. Frederick Raal
Added value of sGC stimulator in worsening HFrEF patients
Added value of sGC stimulator in worsening HFrEF patients
ACC 2020
Added value of sGC stimulator in worsening HFrEF patients
- Prof. Paul Armstrong, MD
Oral anticoagulant monotherapy reduces bleeding in AF patients after TAVI
Oral anticoagulant monotherapy reduces bleeding in AF patients after TAVI
ACC 2020
Oral anticoagulant monotherapy reduces bleeding in AF patients after TAVI
- Dr. Jur ten Berg